Kenvue Inc. Common Stock vs SPDR Kensho Final Frontiers ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while SPDR Kensho Final Frontiers ETF trades at $103.71 (market cap $170.14M). The key difference: Kenvue Inc. Common Stock is far larger — about 200.2× SPDR Kensho Final Frontiers ETF's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while SPDR Kensho Final Frontiers ETF pays none. Which is the better fit depends on your goals.
| KVUE | ROKT | |
|---|---|---|
Market Cap | $34.06B | $170.14M |
Volume | 23,267,228 | 12,298 |
Sector | Consumer Staples | Sector/Thematic |
52-Week High | $19.83 | $136.68 |
52-Week Low | $14.11 | $72.93 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 9 Days |
Trailing returns across standard periods
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →SPDR Kensho Final Frontiers ETF seeks exposure to companies supporting exploration of outer space and the deep sea. Its holdings include businesses involved in aerospace, defense, communications, research, and related technologies.
Read more on ROKT →